Compare ASTE & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASTE | MRVI |
|---|---|---|
| Founded | 1972 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.0B |
| IPO Year | 2003 | 2020 |
| Metric | ASTE | MRVI |
|---|---|---|
| Price | $41.33 | $5.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $66.00 | $4.13 |
| AVG Volume (30 Days) | 248.3K | ★ 2.0M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.85% | N/A |
| EPS Growth | ★ 784.21 | 14.29 |
| EPS | ★ 0.51 | N/A |
| Revenue | N/A | ★ $185,743,000.00 |
| Revenue This Year | $14.72 | $12.54 |
| Revenue Next Year | $5.44 | $7.87 |
| P/E Ratio | $84.80 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $40.47 | $2.29 |
| 52 Week High | $65.69 | $7.44 |
| Indicator | ASTE | MRVI |
|---|---|---|
| Relative Strength Index (RSI) | 24.87 | 36.84 |
| Support Level | $40.47 | $5.54 |
| Resistance Level | $63.89 | $6.55 |
| Average True Range (ATR) | 2.23 | 0.31 |
| MACD | -0.57 | -0.12 |
| Stochastic Oscillator | 0.15 | 25.37 |
Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. The company has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.